Literature DB >> 21505042

Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome.

Mary C Taylor1, A Reema Kar, Allen R Kunselman, Christy M Stetter, Andrea Dunaif, Richard S Legro.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a familial syndrome, associated with multiple cardiovascular disease (CVD) risk factors. Thus, parents of affected women may have a higher prevalence of CVD events than the general population.
METHODS: PCOS probands (n = 410) and their participating parents (n = 180 fathers and 211 mothers) were queried for CVD events in themselves and non-participating family members. In order to include the family CVD history of all parents, agreement between the proband and parental reports of CVD events was assessed. Estimated 10-year coronary heart disease (CHD) risk was calculated using the Framingham risk calculator. The National Health and Nutrition Examination Survey (NHANES) 2001-2002 database was used to generate gender, age and body mass index-relevant population parameters of CVD prevalence in the USA population.
RESULTS: Ninety-eight percent of the parents' self-reporting of CVD events agreed with the proband's report of parental heart attack history [Kappa = 0.82; 95% CI: (0.69, 0.94)] and 99% with parental stroke history [Kappa = 0.79; 95% CI: (0.62, 0.97)]. Fathers of women with PCOS had a higher prevalence of heart attack and stroke compared with the reference NHANES population (heart attack: 11.1 versus 5.3%, P < 0.0001; stroke: 3.0 versus 1.0%, P = 0.002). Fathers of women with PCOS had an elevated 10-year risk for CHD (11.5 versus 9.9% in NHANES, P = 0.03). No statistically significant increased prevalence of CVD events or 10-year risk was noted in probands or mothers.
CONCLUSIONS: Fathers, and not mothers, may be disproportionately burdened with CVD in PCOS families. The strengths of this study include the size of our cohort, the consistent phenotyping and the validation of proband's reporting of parental CVD events.

Entities:  

Mesh:

Year:  2011        PMID: 21505042      PMCID: PMC3137384          DOI: 10.1093/humrep/der101

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  30 in total

1.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield; M K Cavaghan; J Imperial
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

2.  Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.

Authors:  David A Ehrmann; David R Liljenquist; Kristen Kasza; Ricardo Azziz; Richard S Legro; Mahmoud N Ghazzi
Journal:  J Clin Endocrinol Metab       Date:  2005-10-25       Impact factor: 5.958

3.  Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.

Authors:  Murat Yilmaz; Neslihan Bukan; Reyhan Ersoy; Ayhan Karakoç; Ilhan Yetkin; Göksun Ayvaz; Nuri Cakir; Metin Arslan
Journal:  Hum Reprod       Date:  2005-05-12       Impact factor: 6.918

4.  Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women.

Authors:  E Dahlgren; P O Janson; S Johansson; L Lapidus; A Odén
Journal:  Acta Obstet Gynecol Scand       Date:  1992-12       Impact factor: 3.636

5.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 6.  Polycystic ovary syndrome and cardiovascular disease: a premature association?

Authors:  Richard S Legro
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

7.  Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.

Authors:  Rose C Christian; Daniel A Dumesic; Thomas Behrenbeck; Ann L Oberg; Patrick F Sheedy; Lorraine A Fitzpatrick
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.

Authors:  Annemarie G M G J Mulders; Joop S E Laven; Marinus J C Eijkemans; Frank H de Jong; Axel P N Themmen; Bart C J M Fauser
Journal:  Hum Reprod       Date:  2004-06-24       Impact factor: 6.918

View more
  9 in total

1.  Birth weight and childhood growth in daughters of women with irregular menstrual cycles.

Authors:  Erica T Wang; Piera M Cirillo; Chia-Ning Kao; Barbara A Cohn; Marcelle I Cedars
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

Review 2.  Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.

Authors:  Laura C Torchen
Journal:  Curr Diab Rep       Date:  2017-11-11       Impact factor: 4.810

3.  Is PCOS an inflammatory process?

Authors:  Antoni J Duleba; Anuja Dokras
Journal:  Fertil Steril       Date:  2012-01       Impact factor: 7.329

4.  Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome.

Authors:  Arunachalam Sasidevi; Priyathama Vellanki; Allen R Kunselman; Nazia Raja-Khan; Andrea Dunaif; Richard S Legro
Journal:  Hum Reprod       Date:  2012-12-20       Impact factor: 6.918

Review 5.  Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Bulent Yilmaz; Priyathama Vellanki; Baris Ata; Bulent Okan Yildiz
Journal:  Fertil Steril       Date:  2018-01-11       Impact factor: 7.329

Review 6.  Longterm management of Polycystic Ovarian Syndrome (PCOS).

Authors:  Gordon W Bates; Richard S Legro
Journal:  Mol Cell Endocrinol       Date:  2012-12-20       Impact factor: 4.102

Review 7.  [Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].

Authors:  Michael Feichtinger; Tina Stopp; Christian Göbl
Journal:  Wien Med Wochenschr       Date:  2016-03

8.  Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome.

Authors:  Laura C Torchen; Ajay Kumar; Bhanu Kalra; Gopal Savjani; Ryan Sisk; Richard S Legro; Andrea Dunaif
Journal:  Fertil Steril       Date:  2016-04-01       Impact factor: 7.329

9.  Endocrinological and metabolic characteristics in patients who are non-obese and have polycystic ovary syndrome and different types of a family history of type 2 diabetes mellitus.

Authors:  Yuan Wang; Hua Gao; Wen Di; Zhuowei Gu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.